Cincera Therapeutics is a biotechnology company based in Melbourne, Australia which focuses on developing treatments for fibrotic diseases and cancer. Their mission is to design, develop and deliver therapeutic solutions that can effectively halt and reverse the progression of diseases linked to fibrosis, a condition characterised by the excessive accumulation of scar tissue.

The company's team of experienced researchers and clinicians utilise their scientific expertise to devise targeted therapeutics. Their research is targeted towards understanding the underlying mechanisms of fibrosis and cancer, and using this knowledge to develop therapeutics that can provide significant benefits to patients. Cincera Therapeutics is committed to improving the lives of patients and transforming the landscape of healthcare with their ground-breaking research and development.

Connect